JADO Technologies, a spin-out from the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, is developing small molecules that target cell membrane receptors, opening up a potential new avenue for drug delivery.
Everyone wants to encourage innovation. But, says Alain de Serres from the OECD, a survey of the world’s leading industrial countries shows they are going about it in different ways and with very different results.
134,073: the number of patents filed for via the Patent Cooperation Treaty in 2005, according to the World Intellectual Property Organization – a rise of 9.4 per cent over 2004.
French researchers have discovered that an anti-rejection drug could treat Huntington's disease. Intellectual Property based on the research is available for licence.
Researchers in Denmark have invented a bioplastic material made from dairy products that could replace traditional polymer-based packaging. The technology is currently available for licensing.
In the past five years the state of Saxony in the former East Germany has made great strides in creating a biosciences sector – outstripping progress made by some of its counterparts in the more prosperous west of the country.
Ireland's fastest-growing companies hired even more aggressively than other top job-creating European companies during 2001-2004, according to a survey conducted by Entrepreneurs for Growth, a membership-based organisation representing 2,000 European firms.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.